BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013

Mar 4, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-02-28

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-28	Common Stock	M	5000	$12.99	Acquired	18545	Indirect
2013-03-04	Common Stock	M	5000	$12.99	Acquired	23545	Indirect
2013-02-28	Common Stock	S	5000	$58.00	Disposed	18545	Indirect
2013-03-04	Common Stock	S	5000	$60.00	Disposed	13545	Indirect
2013-03-01	Common Stock	S	1000	$59.14	Disposed	119401	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-04	Stock Option (right to buy) Common Stock	$12.99	M	5000	Disposed	2016-05-10	Common Stock (5000)	Indirect
2013-02-28	Stock Option (right to buy) Common Stock	$12.99	M	5000	Disposed	2016-05-10	Common Stock (5000)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10000	Indirect
Common Stock	10000	Indirect
Common Stock	10000	Indirect
Common Stock	10000	Indirect
Common Stock	20000	Indirect

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 plan executed on November 12, 2012.

F2: The reporting person and his spouse act as trustees for the Bienaime Family Trust.

F3: The reporting person's spouse is trustee of each child's trust.

F4: This stock option is fully vested, an therefore is currently exercisable for 100% of shares.

F5: Reflects number of stock options outstanding after the transaction from this specific stock option grant.